-
hcup-us.ahrq.gov/datainnovations/raceethnicitytoolkit/about_grants_re.jsp
July 01, 2016 - Patient-Centered Outcomes Research Institute (PCORI)
Investigator : Romana Hasnain-Wynia
Cancer … Investigators :
Scarlett Lin Gomez
Sally Glaser
Daphne Lichtensztajn
Laura Allen
Los Angeles County Cancer … Statistics and Background Reports on Disparities
Cancer among American Indians and Alaska Natives in … Idaho, Oregon, and Washington
Northwest American Indian and Alaska Native Mortality
Cancer among … death in Washington, Idaho, and Oregon
BIRTH CERTIFICATE DATA FACT SHEETS: For Idaho and Oregon
CANCER
-
hcup-us.ahrq.gov/reports/spotlights_archive.jsp
December 01, 2019 - Cancer. 2015 Mar 1;121(5):747-57. … , lung cancer, breast cancer, and melanoma. … Read more about this publication
Inpatient survival after gastrectomy for gastric cancer in … Cancer. 2013 Jul 1;119(13):2462-8. doi: 10.1002/cncr.28050. … Pediatr Blood Cancer. 2012 Oct;59(4):685-9.
-
hcup-us.ahrq.gov/reports/natstats/commdx/commdx.htm
October 01, 1999 - Whittle, Steinberg, Anderson et al. ( 1991 )
reported that estimates of cancer incidence rates based … on Medicare claims data
were within 6 percent of estimates using the National Cancer Institute's
Surveillance … For example, in Table 1, the ninth ranked procedure (P9),
hysterectomy, is performed for benign neoplasm … Cancer of the prostate, which was 60th in 1992, ranked 81st 4 years later. … Accuracy
of Medicare claims data for estimation of cancer incidence and resection rates
among elderly
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2012_MaskedStats_Severity_V2.PDF
January 01, 2012 - electrolyte disorders 13,459,216 0 0.00 1.00 0.21 0.41
CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,459,216 0 0.00 1.00 0.11 0.31
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 11,811 0.09%
110: Ear, nose, mouth, throat, cranial/facial malignancies … 7,576 0.06%
681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 9,897 0.07%
690 … 18,144 0.13%
692: Radiotherapy 1,115 0.01%
693: Chemotherapy 58,907 0.44%
694: Lymphatic & other malignancies
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2011_MaskedStats_V2_Severity.PDF
January 01, 2011 - electrolyte disorders 13,915,176 0 0.00 1.00 0.21 0.40
CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,915,176 0 0.00 1.00 0.10 0.31
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 12,699 0.09%
110: Ear, nose, mouth, throat, cranial/facial malignancies … 18,617 0.13%
692: Radiotherapy 1,207 0.01%
693: Chemotherapy 61,609 0.44%
694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,416 0.09%
710: Infectious & parasitic diseases including HIV w
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2010_MaskedStats_Severity_V2.PDF
January 01, 2010 - electrolyte disorders 13,907,610 0 0.00 1.00 0.20 0.40
CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,907,610 0 0.00 1.00 0.10 0.30
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 12,922 0.09%
110: Ear, nose, mouth, throat, cranial/facial malignancies … 18,995 0.14%
692: Radiotherapy 1,534 0.01%
693: Chemotherapy 61,552 0.44%
694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,680 0.09%
710: Infectious & parasitic diseases including HIV w
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2013_MaskedStats_Severity.PDF
January 01, 2013 - electrolyte
disorders 14,325,172 0 0.00 1.00 0.22 0.42
CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 14,325,172 0 0.00 1.00 0.11 0.32
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 11,987 0.08%
110: Ear, nose, mouth, throat, cranial/facial malignancies … Percent
of Total
692: Radiotherapy 1,114 0.01%
693: Chemotherapy 62,706 0.44%
694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,072 0.08%
710: Infectious & parasitic diseases including HIV w
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2011_MaskedStats_Severity.PDF
January 01, 2011 - electrolyte disorders 8,023,590 0 0.00 1.00 0.20 0.40
CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 8,023,590 0 0.00 1.00 0.10 0.30
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 6,517 0.08%
110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,946 0.05%
681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 5,098 0.06%
690 … & neoplasms of uncertain behavior 6,509 0.08%
710: Infectious & parasitic diseases including HIV w
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/FileSpecifications_NIS_2008_Severity.TXT
January 01, 2008 - Severity 27 CM_METS 97 98 Num AHRQ comorbidity measure: Metastatic cancer … 2008 Severity 35 CM_TUMOR 113 114 Num AHRQ comorbidity measure: Solid tumor
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/FileSpecifications_NIS_2009_Severity.TXT
January 01, 2009 - Severity 27 CM_METS 97 98 Num AHRQ comorbidity measure: Metastatic cancer … 2009 Severity 35 CM_TUMOR 113 114 Num AHRQ comorbidity measure: Solid tumor
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/FileSpecifications_KID_2009_Severity.TXT
January 01, 2009 - Severity 27 CM_METS 91 92 Num AHRQ comorbidity measure: Metastatic cancer … 2009 Severity 35 CM_TUMOR 107 108 Num AHRQ comorbidity measure: Solid tumor
-
hcup-us.ahrq.gov/toolssoftware/comorbidityicd10/CMR-User-Guide-v2025-1.pdf
November 01, 2024 - • Removed C80.1, Malignant (primary) neoplasm, unspecified, and
R180, Malignant ascites, as these … are not indicative of metastatic
cancer. … • Focused this measure on solid malignant tumors without metastasis,
starting with v2021.1. … • Added diagnosis codes that align with the National Cancer
Institute’s classification of cancer … Additionally, added diagnosis codes indicative of cancers
of the skin.
-
hcup-us.ahrq.gov/toolssoftware/comorbidity/comoanaly_01.txt
December 08, 2004 - DM DMCX HYPOTHY RENLFAIL LIVER
ULCER AIDS LYMPH METS TUMOR … **********************************************/
IF HTNCX = 1 THEN HTN = 0 ;
IF METS = 1 THEN TUMOR … AND CANCFLG THEN TUMOR = 0;
IF ARTH AND ARTHFLG THEN ARTH = 0;
IF COAG AND DRG = 397 THEN COAG … immune deficiency syndrome'
LYMPH = 'Lymphoma'
METS = 'Metastatic cancer … '
TUMOR = 'Solid tumor w/out metastasis'
ARTH = 'Rheumatoid arthritis
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2014_MaskedStats_Severity.PDF
January 01, 2014 - Variable / Label
N
N
Miss Minimum Maximum Mean Std Dev
CM_METS : AHRQ comorbidity measure: Metastatic
cancer … measure: Renal
failure 7,071,762 0 0.00 1.00 0.11 0.31
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,370 0.08%
110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,499 0.05%
681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,365 0.06%
690 … Percent
of Total
692: Radiotherapy 586 0.01%
693: Chemotherapy 29,695 0.42%
694: Lymphatic & other malignancies
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2015Q1Q3_Severity.PDF
November 08, 2017 - electrolyte
disorders 5,377,720 0 0.00 1.00 0.22 0.42
CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 5,377,720 0 0.00 1.00 0.11 0.32
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 3,979 0.07%
110: Ear, nose, mouth, throat, cranial/facial malignancies … 2,580 0.05%
681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 3,152 0.06%
690 … & neoplasms of uncertain behavior 3,745 0.07%
710: Infectious & parasitic diseases including HIV w
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2013_MaskedStats_Severity.PDF
January 01, 2013 - Variable / Label
N
N
Miss Minimum Maximum Mean Std Dev
CM_METS : AHRQ comorbidity measure: Metastatic
cancer … measure: Renal
failure 7,119,563 0 0.00 1.00 0.10 0.30
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,780 0.08%
110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,581 0.05%
681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,512 0.06%
690 … Percent
of Total
692: Radiotherapy 664 0.01%
693: Chemotherapy 30,425 0.43%
694: Lymphatic & other malignancies
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2012_MaskedStats_Severity.PDF
January 01, 2012 - electrolyte
disorders 3,195,782 0 0.00 1.00 0.08 0.27
CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 3,195,782 0 0.00 1.00 0.00 0.06
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 4,907 0.15%
110: Ear, nose, mouth, throat, cranial/facial malignancies … for APRDRG
APRDRG Frequency
Percent
of Total
693: Chemotherapy 32,305 1.01%
694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 475 0.01%
710: Infectious & parasitic diseases including HIV w O.R
-
hcup-us.ahrq.gov/reports/methods/2010_03.pdf
January 01, 2010 - of head and
neck
32
(3)
29
(3)
7.67
(0.19)
6.221
(c)
3.77
(0.39)
6.591
(c)
12: Cancer of … of rectum and
anus
47
(2)
37*
(3)
8.58
(0.11)
7.881
(c)
3.08
(0.21)
3.571
(c)
16: Cancer … of uterus 41
(2)
30*
(3)
4.19
(0.10)
4.151
(c)
1.26
(0.14)
1.351
(c)
26: Cancer of cervix … 23
(1)
20
(2)
3.55
(0.09)
3.661
(c)
1.60
(0.18)
0.791
(c)
27: Cancer of ovary 25
(1)
25
(3) … 6.76
(0.15)
6.001
(c)
4.48
(0.38)
3.971
(c)
30: Cancer of testis 2
(0)
--1
(a)
6.31
(0.39
-
hcup-us.ahrq.gov/db/nation/nis/reports/2007niscomparisonrpt.jsp
May 01, 2016 - of uterus
41 (2)
30* (3)
4.19 (0.10)
4.15 1 (c)
1.26 (0.14)
1.35 1 (c)
26: Cancer … of cervix
23 (1)
20 (2)
3.55 (0.09)
3.66 1 (c)
1.60 (0.18)
0.79 1 (c)
27: Cancer … of ovary
25 (1)
25 (3)
6.76 (0.15)
6.00 1 (c)
4.48 (0.38)
3.97 1 (c)
30: Cancer … of testis
2 (0)
-- 1 (a)
6.31 (0.39)
-- 1 (a)
2.38 (0.79)
-- 1 (a)
32: Cancer of … bladder
38 (2)
34 (3)
6.23 (0.18)
5.48 1 (c)
3.13 (0.22)
1.79 1 (c)
35: Cancer
-
hcup-us.ahrq.gov/reports/statbriefs/sb82.pdf
December 01, 2009 - ■ Increases in cost per stay
contributed notably to the
growth of aggregate costs of
stays for cancer … HCUP data include OB-GYN, ENT,
orthopedic, cancer, pediatric, public, and academic medical hospitals … 88,500 68.6% 40.8%
Aortic resection; replacement or
anastomosis $1,872,908,000 61,600 38.5% 31.9%
Cancer … $93,480,000
(5.0%) 63.6% 34.4% $402,210,000
(21.5%) 37.8% 34.2% $38,269,000
(2.0%) 64.0% 113.4%
Cancer … drainage of skin ($1.1 billion)
Lobectomy or pneumonectomy ($1.8 billion)
Spinal fusion ($8.9 billion)
Cancer